Member Info for travel_light

That’s not too ****ty

I’m looking forward to giving my parents a hug, going to see ZZ Top before they retire, getting on a bus, and seeing health care workers treated like they matter when it come to pay rise.
But also a small glow of satisfaction having invested in a great company which stepped up its game when needed, proved its technology and helped bring about the image above.

Go Avacta and Cytiva we are rooting for you!

RD is shares like Amzn you can buy part shares on some brokers. Lots of small investors can’t afford full share. They are liquid enough that you can buy and sell easily.

This is taken from an old interview, doesn’t provide dates. Watch the news feeds anyone who just arrived.

I know we agreed to split and segment, but Clueless Clive in marketing is whining about how he can't get the agency to get three (now four ) lots of materials in place. He needs a good arse kicking.

As for sniffles not being top end, I got a Prince Charles look-a-likey developing a corker of a nose drip. We need to dub over him as he has a broad Glasswegian accent . "Ye kanna beet a sniffle spit stick fur keep yeerselv and the bairns safe" isn't really gelling yet and Clive is having another melt down in the toilet.

please help Clive with some ideas, otherwise we are looking at skiploads of tests in off white.

I have to admit GnG has a certain charm, but it's a cheeky Ozzie red to SSS Grand Cru Chablis, and I am sure we want a quality image. As for HIGF4U, it's more of a Peruvian White, 4 for a tenner in the end bins at Aldis. Market segmentation is good to do, but for launch I think we need to lead with quality first.

I thought we agreed it was going to be called the Sniffles Spit Stick, PL have you talked to marketing?

I think there are a fair few flu vaccines ready to go?

Sweden not shut down, but then again not back to normal. construction, road building etc ongoing. Cafe open but tables spaced 2m apart. kids under 16 in school, old people homes now being isolated and managed (at last, bloody shameful initial program)

There is a half way path to crashing the economy or sitting on a beach with 5000 others. That path with tracking and testing contacts regardless of symptoms would seem a reasonable. The faster the tracking and testing, the faster we can deal with the infection.

more of a concern is flu season coming, what are the plans. Even if we don't have a vaccine for covid, lets make sure that we don't have people turning upto doctors with c-19 like symptoms. If I was government I would be buying in flu vaccine by the truck load for later.

PL can I have a signed copy of your book when it comes out?

my guess, spit into collection tube, then small pipette used to transfer a measured dose to test point on the LFD.

its a guess-

Thanks. I wonder if that makes it better or worse than antibodies who have longer half life’s I think.

Saw the one study that I “showed” pd-1 antibody more effective than PD-L1. Accumulation in liver meant higher dosage required to hit tumour, but must admit I was having to look up the long words.

Nearly Everything else dropped yesterday in US, so move isn’t such a surprise. It doesn’t require minute analysis :-)

2 more points on the sonic oscillator.....

Interesting, but focused on antibody based test, issues with false +ve due to antibodies towards common cold etc. Bits a little too technical for example LFD has only a few seconds contact time for protein.I skipped over some bit at the start, covid 19 history, and may have missed something. Affimers were mentioned on a slide.

On the recoding there was issues with q+a, there was none.

as for tap dancing it was pretty good till he fell in the sink.

thanks, gave up with iphone, worked great with Mac.

When you say package is that acquisition, licensing virus neutralizing or all therapeutics ?

I am surprised that given the money in antibodies more hasn’t been done to push this forward. Guess the big guys are happy to spend big bucks once big risk removed.

Oh a bit of tap.

Anyone got a link to a recording ?

The webinar with Klaus, where he was cautious, I definitely got the impression that antibody based tests were hard. Bigger molecule which might. E harder to keep stable.

No idea, but maybe a question for his next appearance. Which is easier to work with affimer or antibody. Hope the answer is the one we hope for :-)

FF

I think it is

Abstract:
COVID-19 is pandemic that is currently taking lives and forcing massive constraints of social life and businesses globally. A large number of efforts is now going on to develop rapid tests that allow for either detecting the virus direct or antibodies patients have raised against it. This webinar is about the basics of COVID-19, and the options to develop rapid test systems

Dr H is a membrane based detection specialist according to the Bio.

Yeah it’s nuts. The value against competitors....

Everything looking a little over valued at the mo apart from Avacta ;-)